ReviewBMC cardiovascular disorders2025
Familial hereditary cardiac myxoma: report of three cases and literature review.
Review in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- When Benign Is Not Benign: Lessons From Recurrent Cardiac Myxoma.JACC. Case reports · 2026Article
- Editorial: introducing special collection on cancer and cardiovascular disorders.BMC cardiovascular disorders · 2026Article
- Cross-platform evaluation of LLM-generated educational texts on cardiac myxoma: quality, readability, and actionability using network analysis and latent profile analysis.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundCardiac myxoma, the most common primary benign cardiac tumor, carries a risk of embolization and can be life-threatening. It typically arises in the left atrium but may involve any cardiac chamber. Myxomas may occur sporadically, have familial origins, or present as part of Carney's syndrome. CASE PRESENTATION: Three cases of cardiac myxoma are presented; two involved a father-daughter pair with familial myxoma, while one patient presented with acute exacerbation and was diagnosed postoperatively. Echocardiography and Computed Tomography Angiography (CTA) revealed intracardiac space-occupying lesions suggestive of myxoma. Elective atrial resection was performed under cardiopulmonary bypass; histopathology confirmed the diagnosis. Genetic testing identified a Protein Kinase cAMP-Dependent Type I Regulatory Subunit Alpha (PRKAR1A) gene mutation.
conclusionsPaternal-to-daughter transmission of PRKAR1A mutations is uncommon compared with typical familial cardiac myxomas. All three cases in this series represent this transmission pattern. Surgical resection resulted in a favorable recovery without sequelae. Timely diagnosis and intervention are essential to prevent complications, and regular follow-up is necessary to detect recurrence. This study reports three cases of familial cardiac myxoma and includes a literature review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.